Cai, Ti
Merck Healthcare KGaA, Darmstadt (Germany)
3 papers on CoChat
Most cited papers
- Verified
NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature
NF-κB Signaling PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 535
- Verified
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
Hagner, P. R., Man, H.-W., Fontanillo, C., Wang, M., Couto, S., Breider, M., Bjorklund, C., Havens, C. G., Lu, G., Rychak, E., et al. (2015) · Blood
Protein Degradation and InhibitorsLymphoma Diagnosis and Treatment
Cited by 203
- Verified
Gut-associated checkpoint as a prognostic biomarker in metastatic renal cell carcinoma (mRCC): Results from a randomized first-line clinical trial.
Saliby, R. M., Machaalani, M., Zhong, C., Alves Costa Silva, C., Labaki, C., Saad, E., Steiner, C., Yekeduz, E., Eid, M., Daoud Khatoun, W., et al. (2025) · Journal of Clinical Oncology
Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free